No abstract available.
Carcinoma, Endometrioid*

No abstract available.
Carcinoma, Endometrioid* ; Uterus*

No abstract available.
Adenocarcinoma* ; Carcinoma, Endometrioid*

Simultaneous endometrioid carcinoma of the endometrium and ovary was also called 'endometrioid systematic carcinoma'. This disease was not common with the rate of 5.2% of all endometrial carcinomas. This malignant epithelial neoplasm was presented with high differentiation (Grade 1), and it was often detected at early stages (0; 1A: 1B). Their common symptoms were abnormal metrorrhagia associating with ovarian cyst in young women having low parity. The determined diagnosis based on macroscopic and microscopic description, which could be a key significance in classification of this special lesion
Uterine Neoplasms ; Ovary ; diagnosis ; Carcinoma, Endometrioid

BACKGROUND: For endometrioid carcinoma patients, International Federation of Gynecologists and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate treatment method. However, the interobserver discrepancy with this three-tiered grading system is a serious potential problem. In this study, we used immunohistochemistry to analyze the relationship between FIGO histologic grading score and myoferlin expression. METHODS: We studied the endometrioid carcinoma tissues of 60 patients from Gyeongsang National University Hospital between January 2002 and December 2009. Immunohistochemical analysis of myoferlin was performed on tissue microarray blocks from surgical specimens. RESULTS: Myoferlin expression was observed in 58 of 60 patients. Moderate and strong myoferlin expression was observed in low-grade endometrioid carcinoma, while there was a tendency toward loss of myoferlin expression in high-grade endometrioid carcinoma (p < .001). CONCLUSIONS: Our study revealed that myoferlin loss is significantly correlated with high FIGO grade of endometrioid carcinoma.
Carcinoma, Endometrioid ; Drug Therapy ; Humans ; Immunohistochemistry ; Methods

Primary carcinoma of the fallopian tube is a rare entity that accounts for about 1% of all gynecologic malignancies, and most are discovered during or after surgery. Primary transitional cell carcinoma of the fallopian tube is an extremely rare tumor that is reported only occasionally in the worldwide literature. Histologically, fallopian tube carcinomas are almost always papillary adenocarcinomas, but other histologic types such as endometrioid carcinoma, clear cell carcinoma, and mixed carcinoma have been reported. As primary transitional cell carcinoma (TCC) of the fallopian tube is so rare, the clinicopathologic characteristics are as yet unknown. The authors recently experienced a case of primary transitional cell carcinoma arising in the fallopian tube, and thus report the clinical features, management, and also a review of the past pertinent literature.
Adenocarcinoma, Papillary ; Carcinoma, Endometrioid ; Carcinoma, Transitional Cell* ; Fallopian Tubes* ; Female

No abstract available.
Ascitic Fluid ; Carcinoma, Endometrioid ; Carcinoma, Neuroendocrine ; Endometrium ; Female

OBJECTIVE: Extrauterine involvement of endometrial carcinoma has a significant effect on the patients' prognosis and treatment decision. In classical method, macroscopic section is taken from the fallopian tube sparing the fimbrial ends. Fimbrial end of fallopian tube may be involved by tumors and precursor lesions. This study aims to determine the importance of sampling of fimbrial ends of fallopian tube in endometrioid endometrial carcinoma specimens. METHODS: We reevaluated the fallopian tubes of 200 cases of endometrioid endometrial carcinoma cases that have no macroscopic tubal lesion. A hundred cases were sampled with classical method, and the other 100 were sampled with a new method that includes the fimbrial ends. Statistical difference was examined by Fisher's exact test. RESULTS: No microscopic tubal lesion lesion was detected in cases that were sampled with the classical method. In contrast, there were 4 cases with tubal lesions in patients sampled with the new technique; 3 of them were located in the fimbrial end. Of the 3, there was one microscopic invasive carcinoma and two proliferative endometrial glandular lesions. Endometriosis was detected in two of the 4 cases with tubal lesions. CONCLUSION: Including the fimbrial end of fallopian tube to macroscopic sampling could detect more tubal lesions, which might provide additional prognostic and pathogenetic information of endometrioid endometrial carcinoma.
Carcinoma, Endometrioid ; Endometrial Neoplasms ; Endometriosis ; Fallopian Tubes ; Female ; Humans ; Prognosis

Carcinoma, Endometrioid ; Endometrial Neoplasms ; Female ; Fertility ; Humans ; Retrospective Studies

Female ; Humans ; Consensus ; Endometrial Neoplasms/pathology* ; Carcinoma, Endometrioid/pathology*